A Study of BRT-FC-83C for the Treatment of Atopic Dermatitis

Completed · Phase 2

Conditions studied: Atopic Dermatitis

In brief

The purpose of the study is to determine whether the topical application of BRT-FC-83C is effective in the treatment of mild to moderate atopic dermatitis.

Key facts

Study ID

NCT00883311

Run by

Biomed Research & Technologies, Inc.

People needed

32

Starts

2009-01-01

Expected to finish

2009-07-01

Last updated by the study team

2010-08-31

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinically verified mild to moderate atopic dermatitis. Atopy diagnosis based on clinical scores of 3-7.5 based on the Rajka and Langeland criteria
• Men or women ages 18-50 years
• At least one mild to moderate atopic lesion involving no more than 20% Body Surface Area (BSA)
• Active atopic dermatitis for at least 3 years
• Willingness to cooperate and participate by following study requirements
• Written informed consent

You may not qualify if…

• Individuals with actively oozing atopic lesions
• Individuals who are smokers
• Individuals with insulin-dependent diabetes mellitus
• Individuals that are known to be pregnant, nursing, or planning to become pregnant within the next six months after enrollment
• Individuals currently participating in another clinical usage study that would interfere with this study

Where it is running

• Thomas J. Stephens & Associates, Inc. — Colorado Springs, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.